Home › Burkitt Lymphoma › Wisconsin › Milwaukee
Burkitt Lymphoma clinical trials in Milwaukee, WI
16 studies for Burkitt Lymphoma are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
RecruitingPhase 3
- Medical College of Wisconsin, Milwaukee
Blinatumomab Consolidation in Real World
RecruitingObservational studyHealthy volunteers welcome
- Medical College of Wisconsin, Milwaukee
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
RecruitingPhase 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi away
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi away
- and 1 more
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RecruitingPhase 2
- Children's Hospital of Wisconsin, Milwaukee
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecruitingPhase 3
- Medical College of Wisconsin, Milwaukee
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 1
- Medical College of Wisconsin, Milwaukee
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecruitingPhase 3
- Children's Hospital of Wisconsin, Milwaukee
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
RecruitingPhase 1/2
- Research Site, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
RecruitingPhase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Recruiting
- Children's Wisconsin, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
RecruitingObservational study
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
RecruitingPhase 2
- Children's Hospital of Wisconsin, Milwaukee
Burkitt Lymphoma trials in other cities
- Houston, TX21 studies
- Philadelphia, PA16 studies
- New York City, NY14 studies
- Chicago, IL14 studies
- Cincinnati, OH12 studies
- Atlanta, GA12 studies
- Seattle, WA11 studies
- Durham, NC10 studies
- Boston, MA10 studies
- Kansas City, MO10 studies
- Aurora, CO10 studies
- Los Angeles, CA10 studies
Other studies in Milwaukee
- Breast Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Cancer (all types)22 studies
- Lung Cancer21 studies
- Multiple Myeloma21 studies
- Prostate Cancer20 studies
- Follicular Lymphoma19 studies
- Pancreatic Cancer18 studies
- Non-Hodgkin Lymphoma18 studies
- Ovarian Cancer17 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.